Cancer incidence and mortality rates decreasing in Alberta: new data CT scan offers early window on cardiovascular riskCoronary artery calcium score identifies younger adults in danger of an MI Study reveals how stress may increase risk of heart disease and stroke Brain’s amygdalar activity ‘robustly’ predicts cardiovascular events, researchers find Your patient has a lower GI bleed on ASA—Do you resume antiplatelet therapy? Study suggests balance favours resumption, to reduce cardiovascular risk Bleeding risk increased with dabigatran-statin combo Study of Ontario seniors suggests caution needed with simvastatin and lovastatin Clinical Feature: Update on managing dyslipidemia A review of the updated Canadian Cardiovascular Society guidelines for dyslipidemia management. Edoxaban (Lixiana) approved in Canada Fourth direct-acting oral anticoagulant expected to reach Canadian market in early 2017. Relative cardiovascular safety of celecoxib confirmed COX-2 inhibitor is ‘non-inferior’ to ibuprofen and naproxen, trial shows Anticoagulant antidote works Beyond statins: What you need to know about alternative lipid-lowering agents First Previous 43 44 45 46 47 Next Last
